{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05503732",
            "orgStudyIdInfo": {
                "id": "21-012902"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Effects of Energy Drinks on Sleep and Cardiovascular Health",
            "officialTitle": "Effects of Energy Drinks on Sleep and Cardiovascular Health in Healthy Young Adults A Double Blind Randomized Clinical Trial",
            "therapeuticArea": [
                "Other"
            ],
            "study": "effects-of-energy-drinks-on-sleep-and-cardiovascular-health"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-09-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-07-14",
            "studyFirstSubmitQcDate": "2022-08-15",
            "studyFirstPostDateStruct": {
                "date": "2022-08-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-19",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Anna Svatikova",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to learn about the change in quality of sleep, structural organization of sleep, and cardiovascular responses after consuming an energy drink compared to a placebo drink with no caffeine or stimulants."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy",
                "Caffeine"
            ],
            "keywords": [
                "Energy Drink"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 45,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Energy drink first, then placebo drink",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will consume two 16-oz energy drinks before sleep for the first study visit, then consume two 16-oz identical looking placebo drink before sleep at the second study visit.",
                    "interventionNames": [
                        "Other: Energy Drink",
                        "Other: Placebo Drink"
                    ]
                },
                {
                    "label": "Placebo drink first, than energy drink",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will consume two 16-oz identical looking placebo drink before sleep at the fist study visit, then consume two 16-oz energy drinks before sleep for the second study visit.",
                    "interventionNames": [
                        "Other: Energy Drink",
                        "Other: Placebo Drink"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Energy Drink",
                    "description": "Two 16-oz energy drinks consumed orally to be finished approximately 4 hours prior to bed",
                    "armGroupLabels": [
                        "Energy drink first, then placebo drink",
                        "Placebo drink first, than energy drink"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo Drink",
                    "description": "Two 16-oz identical looking placebo drink without caffeine consumed orally to be finished approximately 4 hours prior to bed",
                    "armGroupLabels": [
                        "Energy drink first, then placebo drink",
                        "Placebo drink first, than energy drink"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Changes in sleep efficiency",
                    "description": "Time asleep / time in bed",
                    "timeFrame": "Throughout duration of sleep on both nights (night 1 and night 2)"
                },
                {
                    "measure": "Changes in sleep continuity",
                    "description": "Frequency of wakefulness after sleep initiation",
                    "timeFrame": "Throughout duration of sleep on both nights (night 1 and night 2)"
                },
                {
                    "measure": "Changes in sleep architecture",
                    "description": "Time spent in each stage of sleep",
                    "timeFrame": "Throughout duration of sleep on both nights (night 1 and night 2)"
                },
                {
                    "measure": "QT segment",
                    "description": "QT duration",
                    "timeFrame": "Baseline, approximately 1 hour prior to energy drink consumption"
                },
                {
                    "measure": "QT segment",
                    "description": "QT duration",
                    "timeFrame": "Throughout duration of sleep on both nights (night 1 and night 2)"
                },
                {
                    "measure": "Atrial arrhythmias",
                    "description": "Frequency of ectopic atrial beats",
                    "timeFrame": "Baseline, approximately 1 hour prior to energy drink consumption"
                },
                {
                    "measure": "Atrial arrhythmias",
                    "description": "Frequency of ectopic atrial beats",
                    "timeFrame": "Throughout duration of sleep on both nights (night 1 and night 2)"
                },
                {
                    "measure": "Ventricular arrhythmias",
                    "description": "Frequency of ectopic ventricular beats",
                    "timeFrame": "Baseline, approximately 1 hour prior to energy drink consumption"
                },
                {
                    "measure": "Ventricular arrhythmias",
                    "description": "Frequency of ectopic ventricular beats",
                    "timeFrame": "Throughout duration of sleep on both nights (night 1 and night 2)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Sympathetic activation quantified by changes in plasma norepinephrine",
                    "description": "Plasma norepinephrine while supine",
                    "timeFrame": "Baseline and AM of day 2"
                },
                {
                    "measure": "Sympathetic activation quantified by changes in plasma epinephrine",
                    "description": "Plasma epinephrine while supine",
                    "timeFrame": "Baseline and AM of day 2"
                },
                {
                    "measure": "Sympathetic activation quantified by changes in plasma dopamine",
                    "description": "Plasma dopamine while supine",
                    "timeFrame": "Baseline and AM of day 2"
                },
                {
                    "measure": "Sympathetic activation quantified by urine norepinephrine",
                    "description": "Total urine norepinephrine secretion",
                    "timeFrame": "Approximately 24 hours"
                },
                {
                    "measure": "Sympathetic activation quantified by urine epinephrine",
                    "description": "Total urine epinephrine secretion",
                    "timeFrame": "Approximately 24 hours"
                },
                {
                    "measure": "Sympathetic activation quantified by urine dopamine",
                    "description": "Total urine dopamine secretion",
                    "timeFrame": "Approximately 24 hours"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Changes in resting heart rate",
                    "description": "Seated heart rate",
                    "timeFrame": "Baseline and AM of day 2"
                },
                {
                    "measure": "Changes in resting blood pressure",
                    "description": "Seated systolic and diastolic blood pressure",
                    "timeFrame": "Baseline and AM of day 2"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adults 18 years of age and older.\n* Healthy subjects without known cardiovascular disease and thyroid disease.\n* Subjects who are on no medications (except oral contraceptive pill).\n* Nonsmokers.\n* No prior history of caffeine sensitivity or allergy.\n\nExclusion Criteria:\n\n* Subjects with known cardiovascular or thyroid disease.\n* Subjects currently taking medications other than oral contraceptive pill.\n* Smokers.\n* Prior history of caffeine sensitivity or allergy.\n* Pregnancy.\n* Subjects who regularly consume energy drinks.\n* Subjects who typically go to sleep after midnight.\n* Subjects who traveled across 2 time zones in the last 7 days.\n* Shift workers.\n* Subjects who have or are suspected to have sleep apnea.\n* Subjects who have a body mass index \\> 35kg/m\\^2.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Rochester Cardiovascular Research Unit Preventive Team",
                    "role": "CONTACT",
                    "phone": "507-538-7425",
                    "email": "RSTCVRUPrevent@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Anna Svatikova, MD, PhD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rochester Cardiovascular Research Unit Preventive Team",
                            "role": "CONTACT",
                            "phone": "507-538-7425",
                            "email": "RSTCVRUPrevent@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M5373",
                    "name": "Caffeine",
                    "relevance": "LOW"
                },
                {
                    "id": "T370",
                    "name": "Caffeine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                }
            ]
        }
    },
    "hasResults": false
}